Micot Pharma-B (02335) announced interim results
- Net profitRMB-2.3bn
- Profit attributable to ownersRMB-2.3bn
- Net profit YoY-364.3%
- Depreciation & amortisationHK$6.6M
- Capital expenditureHK$-17.0M
- Interest-bearing debtHK$49.7M
Source Micot Pharma-B
Source Micot Pharma-B

